Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...
Shell (NYSE:SHEL) -2.5% in Wednesday's trading following its disappointing Q4 update, but UBS nevertheless upgrades shares to ...
UBS Securities on Wednesday upgraded PulteGroup (NYSE:PHM) stock to Buy from Neutral, highlighting promising margins, while ...
Wayne Gordon, executive director of commodities at UBS Global Wealth Management, says he expects gold prices to hit $2,850 ...
UBS analysts upgrade Bank of America (BAC) to Buy from Neutral and lift their price target to $53 from $43. The analysts ...
The Swiss bank expects the city’s benchmark index to rise above 20,000 by year-end, implying a gain of 3.7 per cent from ...
We recently compiled a list of the 9 Stocks Poised for Gains as AI Reaches New Heights in 2025. In this article, we are going ...
Nvidia, Microsoft and OpenAI continue their reign as the leaders in artificial intelligence, according to a survey by UBS of IT executives. Read more here.
Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...
Tesla Inc. could collect more than €1 billion ($1 billion) in compensation from rival automakers that need help meeting ...
We recently compiled a list of the 9 Stocks Poised for Gains as AI Reaches New Heights in 2025. In this article, we are going ...
Investing.com -- Nvidia (NASDAQ: NVDA ), Microsoft (NASDAQ: MSFT ), and OpenAI are the key AI beneficiaries, UBS analysts said, citing results of its latest enterprise AI survey. The survey, which ...